Personalized Blood Flow Restriction for Anterior Cruciate Ligament Rehabilitation

February 3, 2022 updated by: Scott Telfer, EngD, University of Washington
This is a cross-sectional study on the use of personalized blood flow restriction during rehabilitation exercises and its effects on biomechanics on people who have had an anterior cruciate ligament reconstruction and healthy controls

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Rehabilitation after surgical reconstruction of the anterior cruciate ligament (ACL) aims to reestablish the function of the knee. However, regaining previous levels of strength is challenging, with long-term muscle weakness frequently reported and thought to play a key role in the increased risk of knee osteoarthritis for individuals with a history of ACL damage. Effectively building muscle strength requires exercises with high resistance loads, however the joint stress and risk of further injury makes these types of activities inappropriate and unsafe for those rehabilitating after ACL reconstruction surgery and other injuries. Personalized blood flow restriction (BFR) training is a technique where the blood flow to the muscles being exercised is controlled by a pressure cuff to a predefined level, and has been shown to increase strength while exercising with significantly lower loads. Early results have been promising, however the effects of BFR on the biomechanics of the exercise as well as the acceptability in the ACL reconstruction population have not been explored. In this application, we propose a cross-sectional study designed to test the acceptability of BFR training for those undergoing rehabilitation from ACL reconstruction surgery and healthy controls during free standing exercises. We will also investigate the biomechanical effects of this rehabilitation technique. This application is part of a larger program of musculoskeletal research in this area being developed by the team. The results from the proposed project will inform the design of a clinical trial of personalized BFR after ACL reconstruction.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98195
        • University of Washington Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria (ACL-R group):

  • Must be undergoing rehabilitation for anterior cruciate ligament reconstruction surgery
  • Must be at least 3 months post surgery.
  • Attending clinician should confirm that they are able to take part in the trial

Exclusion Criteria:

  • Any other orthopaedic, neurological, or other condition within the last 12 months that would affect ability to carry out the required exercises
  • Any medical conditions that may affect circulation including, but not limited to, deep vein thrombosis, high blood pressure, and cardiac disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Anterior cruciate ligament reconstruction group
Single session blood flow restriction of lower limb to individuals who have undergone anterior ligament reconstruction surgery
Intervention restricts blood flow to the lower limb as a percentage of the limb occlusion pressure
Active Comparator: Control group
Single session blood flow restriction of lower limb to individuals who have no musculoskeletal injuries
Intervention restricts blood flow to the lower limb as a percentage of the limb occlusion pressure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Flexion
Time Frame: 6 minutes
Maximum difference in flexion motion of knee while performing exercise between baseline and blood flow restriction condition. Measured in degrees
6 minutes
Knee Internal Rotation
Time Frame: 6 minutes
Maximum difference in internal rotation of knee while performing exercise between baseline and blood flow restriction condition. Measured in degrees
6 minutes
Knee Varus
Time Frame: 6 minutes
Maximum difference in varus motion of knee while performing exercise between baseline and blood flow restriction condition. Measured in degrees
6 minutes
Hip Flexion
Time Frame: 6 minutes
Maximum difference in flexion motion of hip while performing exercise between baseline and blood flow restriction condition. Measured in degrees
6 minutes
Hip Adduction
Time Frame: 6 minutes
Maximum difference in adduction motion of hip while performing exercise between baseline and blood flow restriction condition. Measured in degrees
6 minutes
Hip Internal Rotation
Time Frame: 6 minutes
Maximum difference in internal rotation motion of hip while performing exercise between baseline and blood flow restriction condition. Measured in degrees
6 minutes
Knee Extension Moment
Time Frame: 6 minutes
Maximum difference in extension moment of knee while performing exercise between baseline and blood flow restriction condition. Measured in Newton meters per kilogram
6 minutes
Knee Internal Rotation Moment
Time Frame: 6 minutes
Maximum difference in internal rotation moment of knee while performing exercise between baseline and blood flow restriction condition. Measured in Newton meters per kilogram
6 minutes
Knee Adduction Moment
Time Frame: 6 minutes
Maximum difference in adduction moment of knee while performing exercise between baseline and blood flow restriction condition. Measured in Newton meters per kilogram
6 minutes
Hip Extension Moment
Time Frame: 6 minutes
Maximum difference in extension moment of hip while performing exercise between baseline and blood flow restriction condition. Measured in Newton meters per kilogram.
6 minutes
Hip Adduction Moment
Time Frame: 6 minutes
Maximum difference in adduction moment of hip while performing exercise between baseline and blood flow restriction condition. Measured in Newton meters per kilogram
6 minutes
Hip Internal Rotation Moment
Time Frame: 6 minutes
Maximum difference in internal rotation moment of hip while performing exercise between baseline and blood flow restriction condition. Measured in Newton meters per kilogram
6 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise Difficulty Score
Time Frame: 6 minutes
Numerical Analogue Scale, 0-10, higher scores indicate greater difficulty
6 minutes
Exercise Discomfort Score
Time Frame: 6 minutes
Numerical Analogue Scale, 0-10, higher scores indicate greater discomfort
6 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Scott Telfer, EngD, University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 8, 2018

Primary Completion (Actual)

November 2, 2020

Study Completion (Actual)

November 2, 2020

Study Registration Dates

First Submitted

November 2, 2020

First Submitted That Met QC Criteria

November 13, 2020

First Posted (Actual)

November 19, 2020

Study Record Updates

Last Update Posted (Actual)

February 28, 2022

Last Update Submitted That Met QC Criteria

February 3, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00004543
  • 5P30AR072572-02 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Data will be made available to researchers on request. Dataset includes all kinematic, kinetic and patient reported data.

IPD Sharing Time Frame

11/19/2021 - 11/18/2026

IPD Sharing Supporting Information Type

  • Study Protocol
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Tear

Clinical Trials on Blood flow restriction

Subscribe